Student report--the fight against cancer and angiogenesis inhibitors: are we entering a new era?
Chemoresistance is currently the main cause of failure in the treatment of cancer which, despite extensive research, remains unsolved. In this report the theoretical assumptions underlying antiangiogenic therapy are described and future perspectives and limits are discussed.
Spada
M
M
Faculty of Medicine and Surgery, University of Catania, Italy. ergxjs@tin.it
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors